Elekta AB (EKTAY)
7.246
-0.01
(-0.12%)
USD |
OTCM |
May 08, 15:49
Elekta Revenue (Quarterly): 436.89M for Jan. 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 436.89M |
| October 31, 2023 | 431.41M |
| July 31, 2023 | 362.56M |
| April 30, 2023 | 492.15M |
| January 31, 2023 | 415.03M |
| October 31, 2022 | 379.85M |
| July 31, 2022 | 331.44M |
| April 30, 2022 | 448.64M |
| January 31, 2022 | 399.88M |
| October 31, 2021 | 427.52M |
| July 31, 2021 | 356.21M |
| April 30, 2021 | 433.89M |
| January 31, 2021 | 425.95M |
| October 31, 2020 | 402.08M |
| July 31, 2020 | 319.15M |
| April 30, 2020 | 409.27M |
| January 31, 2020 | 384.50M |
| October 31, 2019 | 382.33M |
| July 31, 2019 | 340.96M |
| April 30, 2019 | 440.46M |
| January 31, 2019 | 367.99M |
| October 31, 2018 | 369.11M |
| July 31, 2018 | 320.83M |
| April 30, 2018 | 413.97M |
| January 31, 2018 | 333.56M |
| Date | Value |
|---|---|
| October 31, 2017 | 358.78M |
| July 31, 2017 | 291.11M |
| April 30, 2017 | 416.45M |
| January 31, 2017 | 293.78M |
| October 31, 2016 | 283.37M |
| July 31, 2016 | 225.39M |
| April 30, 2016 | 433.56M |
| January 31, 2016 | 297.38M |
| October 31, 2015 | 336.01M |
| July 31, 2015 | 267.06M |
| April 30, 2015 | 452.94M |
| January 31, 2015 | 330.74M |
| October 31, 2014 | 362.46M |
| July 31, 2014 | 278.74M |
| April 30, 2014 | 609.83M |
| January 31, 2014 | 365.19M |
| October 31, 2013 | 377.39M |
| July 31, 2013 | 289.76M |
| April 30, 2013 | 580.02M |
| January 31, 2013 | 368.37M |
| October 31, 2012 | 374.33M |
| July 31, 2012 | 241.40M |
| April 30, 2012 | 465.12M |
| January 31, 2012 | 376.21M |
| October 31, 2011 | 295.12M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
319.15M
Minimum
Jul 2020
492.15M
Maximum
Apr 2023
398.93M
Average
402.08M
Median
Oct 2020
Revenue (Quarterly) Benchmarks
| Abliva AB | 0.0129M |
| Karolinska Development AB | 0.0454M |
| Calliditas Therapeutics AB | 42.53M |
| Oncopeptides AB | 0.26M |
| Olink Holding AB | 68.55M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 29.37M |
| Total Expenses (Quarterly) | 382.20M |
| EPS Diluted (Quarterly) | 0.077 |
| Enterprise Value | 3.110B |
| Gross Profit Margin (Quarterly) | 36.68% |
| Profit Margin (Quarterly) | 6.72% |
| Earnings Yield | 4.90% |
| Operating Earnings Yield | 8.45% |
| Normalized Earnings Yield | 4.901 |